Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Wave Life Sciences
Biotech
Wave's ALS-dementia drug crashes out after early-phase flop
The biotech is waving goodbye to WVE-004 after getting a look at early-phase data in amyotrophic lateral sclerosis and frontotemporal dementia.
Nick Paul Taylor
May 23, 2023 9:30am
GSK stands by dumping cell therapies as oligo strategy heats up
Feb 17, 2023 6:30am
Avidity pushes new phase 1/2 data as FDA hold remains in place
Dec 14, 2022 11:00am
GSK pays $170M upfront to continue to ride oligonucleotide wave
Dec 13, 2022 10:24am
Takeda crashes out of Wave discovery pact at cost of $23M
Oct 20, 2021 8:10am
Wave culls leading Huntington's meds as shares go under
Mar 30, 2021 7:40am